Viewing Study NCT02622932


Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2026-03-09 @ 4:09 AM
Study NCT ID: NCT02622932
Status: COMPLETED
Last Update Posted: 2019-04-30
First Post: 2015-12-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer Patients
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords: